GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » Shares Buyback Ratio %

Maat Pharma (XPAR:MAAT) Shares Buyback Ratio % : -20.21 (As of May. 16, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Maat Pharma's current shares buyback ratio was -20.21%.

Maat Pharma Shares Buyback Ratio % Historical Data

The historical data trend for Maat Pharma's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maat Pharma Shares Buyback Ratio % Chart

Maat Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shares Buyback Ratio %
Get a 7-Day Free Trial - -3.88 -0.56 -16.76 -20.21

Maat Pharma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.51 -16.46 -0.26 -19.70 -0.42

Maat Pharma Shares Buyback Ratio % Calculation

Maat Pharma's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(11.605 - 13.950) / 11.605
=-20.21%

Maat Pharma's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Jun. 2024 )
=(13.891 - 13.950) / 13.891
=-0.42%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maat Pharma Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Maat Pharma's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Maat Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » Shares Buyback Ratio %
Comparable Companies
XPAR:TNG XPAR:ADOC XPAR:OSE XPAR:ALSEN XPAR:NANO XPAR:IPH XPAR:ABNX XPAR:ALGAE XPAR:SIGHT XPAR:GNFT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
4RD:Germany
Address
70 Avenue Tony Garnier, Lyon, FRA, 69007
Website
https://www.maatpharma.com
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma Headlines

No Headlines